Primary Site >> Colorectal Cancer

Gene >> RPS6KA2

  • 2007
  • 2009
  • 2011
  • 2012
  • 2014
  • 2016
  • 2017
Ref: Profiling of selenomethionine responsive genes in colon cancer by microarray analysis.
PMID: 17374985
Ref: Carbachol induces p70S6K1 activation through an ERK-dependent but Akt-independent pathway in human colonic epithelial cells.
PMID: 19615971
Ref: Genetic variation in RPS6KA1, RPS6KA2, RPS6KB1, RPS6KB2, and PDK1 and risk of colon or rectal cancer.
PMID: 21035469
Ref: Diet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment.
PMID: 21999454
Ref: Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth.
PMID: 22523035
Ref: Low expression of RSK4 predicts poor prognosis in patients with colorectal cancer.
PMID: 25197367
Ref: Resistance to Selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70S6K and RPS6 activation.
PMID: 25379021
Ref: BRAF V600E inhibition stimulates AMP-activated protein kinase-mediated autophagy in colorectal cancer cells.
PMID: 26750638
Ref: p90 ribosomal S6 kinase: a potential therapeutic target in lung cancer.
PMID: 26791782
Ref: Comparison of anti-inflammatory mechanisms of mango (Mangifera Indica L.) and pomegranate (Punica Granatum L.) in a preclinical model of colitis.
PMID: 27028006
Ref: The ERK1/2 and mTORC1 Signaling Pathways Are Involved in the Muscarinic Acetylcholine Receptor-Mediated Proliferation of SNU-407 Colon Cancer Cells.
PMID: 27167250
Ref: RSK activation via ERK modulates human colon cancer cells response to PTHrP.
PMID: 28385776